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Abstract
The concept of male subfertility has evolved rapidly since 2000. This term is discussed based upon evidence
relating to its first entrance into the literature, along with contemporary references to its purported incidence
and prevalence. Factors affecting sperm quality are described in detail, and available data pertaining to the
effects of micronutrients on spermatic parameters and resulting pregnancies are described. The first cost-
efficiency analysis of the use of micronutrients vs. assisted reproductive technologies is presented. This paper
also describes a therapeutic approach to males, recognizing that many potential fathers have no recourse to
medical facilities to evaluate their fertility. At a time when medical dollars are either nonexistent or precious,
such an approach using micronutrient supplementation may be cost-effective in developing and possibly even
in developed countries.
 
Introduction
Periconceptual vitamin supplementation for women
(before and during pregnancy) has become a worldwide
standard of care. Interestingly, the specific composition of
these supplements has changed dramatically over time. In
the early 1960s, such supplementation consisted of oral
high-dose iron and vitamin pills with only a few compo-
nents. Additional agents were added to multivitamins,
particularly when the value of folic acid in prevention of
neural tube defects was clinically recognized. More
recently, the need to provide folic acid in the first 28d after
conception has been documented, along with the require-
ment to maintain this for three months before conception.
The value of folic acid supplementation has been demon-
strated in population-wide reductions in the incidence of
neural tube defects [1].
The current approach to male partners of women who are
either unable to conceive or who are attempting to become
pregnant is quite different. For men, there has been a ten-
dency to focus upon problem solving for the individual.
This contrasts sharply with broad-based care provided to
women in terms of providing vitamin supplementation
along with a structured program to provide optimal con-
ditions for the gestation. In other words, there is no equiv-
alent structure to offer a broad, public health approach for
“future fathers” as for pre-natal counseling for women.
Indeed, male factor fertility assessments have included
little or no focus on providing vitamin supplementation to
address potential nutrient deficiencies which might affect
semen parameters. While providing optimal nutritional
support to all patients seems logical, many clinicians may
not be aware of how this may find application specifically
to male reproductive potential [2]. For example, recent
research suggests that folic acid administered to men
unable to father children yields increased sperm counts,
improves sperm motility, and reduces abnormal morpho-
logical forms [3].
UNICEF has estimated that a third of the world’s popu-
lation is adversely affected by vitamin and mineral defi-
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nciency [4], a problem associated with substantial eco-
nomic burdens having special relevance to women and
children. Although men were not specifically referenced
in the UNICEF research, it is reasonable to generalize such
findings to males sharing the same environments. The
seriousness of vitamin and mineral deficiency among
males appears valid even for populations where men are
fed first, followed by children, with leftovers being given
to women. In this context, our investigation explores a
therapeutic approach to men who want to father children,
recognizing that many potential fathers worldwide cannot
access medical facilities to evaluate their own fertility
potential.
Changes in understanding of male
subfertility
Fertility describes the potential for actual production of
offspring, while infertility is the inability to reproduce.
According to the American Society for Reproductive
Medicine (ASRM), “infertility is a disease defined as the
inability to conceive following 12 or more months of
unprotected sex before an investigation is undertaken
unless the medical history and physical findings dictate
earlier evaluation and treatment” [5]. As with other
aspects of reproduction, exact figures regarding infertility
etiologies vary, but the cause of infertility is commonly
ascribed to the female in 40–50% of cases, to the male in
40%, to a combination in 20–30%, and remains unex-
plained in 15–20% of instances [6]. The related concept
of subfertility, generally understood to mean a prolonged
time of unwanted nonconception [7], is less familiar. In
clinical settings and in the literature this term often is
incorrectly used synonymously with infertility. Even
whether the term subfertility should be used at all is con-
troversial [7–8], although it can be useful with particular
reference to males who may benefit from a simple inter-
vention such as vitamin supplementation.
As in other aspects of medicine, the taxonomy of male
reproductive potential has been shaped by the insurance
industry; how the medical problem is classified can influ-
ence the reimbursement rate for consultation and therapy
fees. If infertility, meaning the inability to become preg-
nant, is not considered a disease process per se, then such
a medical model would fail to heed the contemporary
approach of health as being “a state of complete physical,
mental and social well-being and not merely the absence
of disease or infirmity” [9]. In this context, subfertility as
an entity distinct from infertility is a useful demarcation,
because such people (especially males) likely represent
the majority of individuals with problems in achieving
pregnancy worldwide.
It is unclear when the term subfertility first appeared in
the literature. It is mentioned in the title of a 1949 article
[10], but since no references accompany the text it is
impossible to determine if the author was the first to intro-
duce this term. In 2005, three articles discussing subfer-
tility appeared in Human Reproduction in a section char-
acterized as “Debate” [7–8,11]. Of interest, this journal is
directed toward specialists in reproductive medicine
rather than the general obstetrician/gynecologist or even
the general physician. Researchers have noted that the
“terminology in reproductive medicine relating to repro-
ductive success is ambiguous, confusing and misleading”
[7]. Given this circumstance, subfertility as a term (espe-
cially when applied to males) will likely remain in use
since it describes a large and specific portion of the male
population—those who are unable to commission a preg-
nancy for varying durations of time but who may indeed
be capable of fathering a child [12]. Further, the term is
less psychologically disturbing to males than is infertility
[13] and may not be as threatening to a man’s concept of
virility as is infertility [14].
Incidence and role of clinical
treatments
The exact frequency of male subfertility is not known.
Among couples investigated for an inability to conceive,
the rates attributable to males range from 25–50%,
although many cases are classified as “unexplained” [11,
15–16]. Whether similar rates prevail in couples not
attending for fertility evaluation is speculative. Interest-
ingly, conceptions can still occasionally occur among cou-
ples who have been labeled infertile, but receive no treat-
ment. One study found a cumulative livebirth rate of
52.5% at 36 months among such individuals [17]. A sim-
ilar conclusion was reported in an observational study of
>9,000 nontreatment months, where a cumulative preg-
nancy rate of 19.9% was noted in a population with
“unwanted nonconception of at least one year’s duration”
[17]. Finally, a slightly lower (14.3%) livebirth rate at 12
months was noted in a 1995 study [15]. These investiga-
tions show that clinical intervention is not absolutely nec-
essary for pregnancy to ensue among patients thought to
be infertile.
Concerns regarding declines in human semen quality and
fertility rates have been expressed for many years [18–
20]. Among the most commonly cited factors associated
with these declines are environmental and occupational
pollutants, changes in lifestyles, exposure to toxic agents,
and changes in dietary habits [13,21]. Recent literature has
also implicated oxidative stress and free radicals, which
impair reproductive potential via gonadal toxicity and
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nassociated altered spermatogenesis [16,22–23]. Causative
mechanisms are investigated only in men who present to
medical caregivers requesting an explanation for their
inability to procreate.
In the healthy individual, reactive oxygen species (ROS)
and antioxidants remain in balance. When this balance is
disrupted in favor of ROS, oxidative stress (OS) occurs
[22]. The production of ROS and reactive nitrogen species
(RNS) is multifactoral [24]. Stated another way, when the
balance of natural antioxidants is depleted, oxidative
stress results in cellular damage [23]. A recent review of
literature has confirmed the positive effect of antioxidants
on reproductive capacity, with particularly strong evi-
dence for carnitines, Vitamin C, and Vitamin E to be con-
sidered first-line therapy for male subfertility [25]. How-
ever, glutathione, selenium, and coenzyme Q-10 had been
subject to fewer investigations and therefore could be con-
sidered only as second-line therapies [25].
Male reproductive potential and
lifestyle factors
Smoking and alcohol often used socially at similar times,
yet studies in the reproductive biology literature do not
always consider their additive detrimental effects. This is
in contrast to the epidemiological literature where their co-
use represents classic synergy [26]. Cigarette smoke con-
tains well-known somatic cell mutagens and potent car-
cinogens; the possibility that this has an adverse effect
upon male reproductive health is not new [23,27]. The
exact mechanism by which sperm damage occurs is not
clear, but may be related to the increased vulnerability of
spermatozoa to oxidative stress given these cells’ high
membrane fraction of polyunsaturated acids [28]. Exces-
sive consumption of alcohol increases ROS levels [16]
and many alcohol abusers consume insufficient dietary
amounts of protective antioxidants [29]. Dietary deficien-
cies have been linked to oxidative damage in spermatozoa
[16–17], but the literature on specific nutrients is often
conflicting. Results of supplementation with folic acid and
zinc are particularly relevant, because they appear to work
synergistically and result in a >70% increase in sperm
concentration when taken under study conditions [30].
Selenium supplementation has been shown to yield a sig-
nificant dose-dependent increase in total sperm count after
26wks, although toxicity was reported at excessive doses
[22].
Numerous environmental pollutants have been linked
with testicular oxidative stress [16]. Among these are air
pollutants such as diesel particulate matter [31], a factor
of special importance in countries that use unleaded auto-
motive fuels. Cadmium and lead have been specifically
linked with sperm oxidative damage [32]; mercury and
arsenic are also toxic to sperm [33]. The male reproductive
system is also adversely affected by agricultural pesticides
and industrial chemicals [33], and illustrates the impor-
tance of recording potential occupational exposures in the
clinical history. Hyperthermia, whether from tight cloth-
ing or from working in a continuous sedentary position
(e.g., truck driving, computer work), has also been impli-
cated in the production of elevated levels of ROS and
RNS, since germinal cells respond to increased tempera-
ture by production of heat-shock proteins [33]. Another
major concern, only beginning now to emerge, is the
potentially negative effect of the continued use of cell
phones. Because this technology is ubiquitous, if it has a
negative effect on spermatic function, it would represent
an important area of future investigation. While not every
cell phone user is unable to father a child, but as cell phone
usage varies enormously among individuals, this potential
risk factor must be quantified. This matter was explored
in a recent Cleveland Clinic study, which reported that
among 361 males attending a clinic for infertility, the use
of cell phones adversely affected semen parameters in an
exposure-dependent manner [34]. Participants were grou-
ped by sperm count (greater or less than 20 million/mL)
and by daily active cell phone use (talking time), from no
use (n=40), <2 hours/day (n=107), 2–4 hours/day (n=100),
and >4 hours/day (n=114). The difference between cell
phone user groups for each parameter was significant,
with differences in motility, viability, and normal mor-
phology among the two sperm count groups (p<.0001).
Sperm DNA damage increases with advancing age in both
fertile and infertile men, possibly because of normal
increases in ROS levels over time [16]. Bacterial and viral
infections can also impair semen parameters [33]. Both
produce leukocytes and granulocytes that are believed to
release various pro-inflammatory cytokines, ROS, and
other bioactive molecules causing oxidative stress, thus
adversely affecting spermatozoa [35]. Psychological
stress reduces semen quality with a central underlying
mechanism being impairment of gonadotropin drive [33].
Stress also reduces sperm quality by increasing plasma
ROS generation and decreasing antioxidant protection
[36].
Extremes of exercise have also been linked with oxidative
stress [16]. Muscle-aerobic metabolism is the cause of
ROS in those who exercise regularly [37]. ROS therefore
may be heightened in those employed in strenuous occu-
pations where physical exertion is routine (i.e., agricul-
tural workers, day laborers, construction, etc). It is note-
worthy that these job classifications often are low-paying
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n(especially in developing countries) and the diets of such
individuals may be more likely to be protein and vitamin/
mineral deficient. Among the obese, adipose tissue relea-
ses pro-inflammatory cytokines that increase leukocyte
production of ROS [35]. Several recent population-based
studies have shown an increased likelihood of abnormal
semen parameters among obese men [16]. The increasing
worldwide prevalence of obesity is of concern to all med-
ical professionals, especially as it is a risk factor for Type
II diabetes mellitus. Hyperglycemia increases ROS and
adversely affects spermatic parameters.
Several medications, chemotherapeutic agents, antimicro-
bials, and radiation may affect gonadal function and can
possibly result in azoospermia [35]. Cannabis, heroin, and
cocaine adversely affect spermatic parameters, but the
extent to which they do so is dependent upon the quantity
and frequency of use [38]. The interplay of known factors
resulting in altered semen parameters is summarized in
Figure 1.
Impact of micronutrient
supplementation on semen
parameters
Medical teaching generally espouses that, among healthy
individuals, nutritional needs can be met by diet alone.
However, this dictum must be reexamined in light of the
evidence that folate supplementation in the absence of
known deficiencies has reduced the incidence of neural
tube defects by 50–60%, both in populations where these
defects were prevalent (e.g., China and India) and in parts
of the world where they were less common [1]. The folate
example highlights the fact that clinicians routinely treat
entire female populations without regard to a known folate
deficiency (the absence of any useful clinical test for folate
deficiency must also be recognized). Such a preventive
treatment strategy works because of the presumption that
some members of a given population are deficient; extend-
ing the possibility of potential folate deficiency to men
[4] therefore seems reasonable. It is also plausible that
folate deficiencies do not exist alone, but rather coexist
with other vitamin, mineral, and/or micronutrient defi-
ciencies.
There is considerable public interest in vitamin supple-
mentation, as 30% of the American public regularly use
such products [11,39]. Ideally, vitamin supplements
should be evaluated in randomized controlled trials with
measurable clinical endpoints, as with pharmaceutical
medications. Because the individual components are
food-based, however, the vitamin industry is outside the
regulatory remit of the FDA. Should such trials be under-
taken, they invariably would be complicated and the
results potentially difficult to interpret given the varied
ingredients and formulations. Of greater importance, sup-
plement manufacturers have no incentive to sponsor such
clinical trials because potential profits do not warrant it.
Given the low cost of standard multivitamins, and recog-
nizing a greater likelihood of benefit over harm with their
use, a daily multivitamin that does not exceed recommen-
ded allowances for all components seems reasonable [40].
This is particularly true because serum measurements for
many micronutrients are not widely available except in
specialized research laboratories. Even in these locations,
such tests are expensive, in contrast to the relatively low
cost of supplementation on an annual basis [40].
Dietary intake of vitamins C, E, and beta-carotene, as well
as folate and zinc, are important for normal semen quality
and reproductive function [25,41–42]. Some investigators
have noted the paucity of published studies on folate and
Figure 1. Overview of known factors resulting in impaired male reproductive potential.
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nmale reproduction [43,44]. One study described zinc
(66mg/d) and folic acid (5mg/d) administered over 26
weeks to 47 fertile and 40 subfertile males, which resulting
in a significant increase in sperm concentration among
subfertile males (no other semen factors were affected)
[45].
Vitamin and mineral deficiencies can occur in settings of
obesity as well as malnourishment. Increasing levels of
obesity in women are seen worldwide, paralleling higher
rates of PCOS with its underlying hormonal imbalance
and gonadal dysfunction. Of interest, the micronutrients
that presently are recognized to function in the etiology of
PCOS are similar to those that affect spermatic parameters
and include calcium, magnesium, chromium, zinc, vita-
min B12, folic acid, inositol (B8), vitamin B6, selenium,
and manganese [46]. Interestingly, clinical testing for any
of these substances is not routinely offered. Although not
widely appreciated, iron absorption is reduced in the pres-
ence of spices or phytates [47–49]. This dietary interplay
is important especially where low levels of nutritious food
intake and high spice consumption is common. When an
individual migrates from an adequate to an inadequate-
but-subclinical mineral status, any resulting impairments
are usually gradual and incremental (see Figure 2). This
decline may be influenced by any number of confounding
factors, including alcohol use, smoking, drugs, and quan-
tity and types of spices in the diet.
Following papers by Wallock et al. [42] and Ebisch et
al. [44], the use of a supplement containing vitamins, min-
erals, and antioxidants was further investigated in two
recent Indian studies. In one national non-randomized
observational study, 81 physicians provided data obtained
from 103 subfertile males [50]. Forty-two of these indi-
viduals received a product (Oligocare) containing 18 com-
ponents including folic acid, iron, manganese, and zinc
(Wellman Conception, Vitabiotics UK). The remaining 61
patients received the same product plus one or more addi-
tional supplements (such as lycopene, co-enzyme Q-10,
vitamin E, and B Complex). In both study groups, sperm
counts more than doubled (18.02 to 46.66 M/ml and 21.66
to 45.88 M/ml, respectively). Patients had complained of
an inability to conceive very shortly after marriage, but
investigations of the male partner were minimal, being
limited to a basic semen analysis. Outcomes were judged
by spontaneous conception. After a median 3 months of
supplementation, pregnancy ensued in 25% of Oligocare
monotherapy couples and in 46% of those who received
Oligocare combination therapy [50]. A subsequent non-
randomized study of azoospermic men (with maturation
arrest verified by testis biopsy) evaluated treatment either
with multivitamins, micronutrients, and co-enzyme Q10
(n=24) or not (n=11) [51]. After three months, the treated
group achieved significant increases in motility and mor-
phology (p<.05) and two pregnancies [51]. With limited
yet growing literature to support the association between
micronutrient deficiency and male subfertility, the subject
appears to be complex and worthy of detailed investiga-
tion. It is difficult to advance many conclusions from the
available research because no standards exist for compar-
ison, either in terms of semen parameters or types of sup-
plementation. For example, whether supplementation
Figure 2. Summary of physiological effects associated with trace element decline (adapted from [48]).
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nshould be provided as monotherapy (i.e., folic acid only)
or a combination of vitamins, minerals, micronutrients,
and antioxidants remains controversial. Combined thera-
pies potentially are more beneficial in managing subfer-
tility because antioxidants act by different mechanisms:
either scavenging oxygenated radicals or improving the
status of enzymatic antioxidants (superoxide dismutase,
catalase, and glutathione peroxidase). If a complex for-
mulation is selected, however, there is no accepted means
to disentangle specific effects of the individual compo-
nents upon semen parameters, a challenge that even
randomized-controlled trials could not fully resolve.
Despite such difficulties, the question posed regarding the
value of micronutrient supplementation is not beyond sci-
entific investigation and is testable. For example, Figure
3 describes a model for future spermatic testing that has
been developed considering the inadequacies of the exist-
ing literature, presenting a potential four-arm study of
supplementation. Large population sampling is essential
for such a research model, washout periods are necessary,
and appropriate follow-up (for both males and females) is
mandatory. Standardization of abstinence before obtain-
ing semen samples would also be necessary.
The economics of male subfertility
Cost analyses of ICSI generally focus on cost per cycle
initiated, cost to achieve a pregnancy, or the additional
cost to achieve a live birth relative to other therapeutic
interventions. Table 1 summarizes three potential costing
analyses for estimating healthcare expenditures related to
alternative approaches to treating involuntary childless-
ness.
The ingredients perspective incorporates a bottom-up
vantage point to estimate unit costs of consumables, pro-
cedures, and hospital costs. The results from such an anal-
ysis would offer a reasonable estimate of the direct costs
relating to procedures delivered in hospital settings. On
the other hand, the society-as-payer perspective would
include expanded costs, such as specialty care required for
neonates and social services for the involuntarily subfer-
tile. The human capital perspective focuses on the patient
with an emphasis on her/his status as a wage-earner and
contributor to the family. Costing analyses may adopt any
or all of these perspectives, as well as others. The human
capital approach is likely to invoke the highest costing
estimates, because the financial consequences of not
working or falling victim to work absenteeism can be
enormous and compound with time. However, when prog-
eny are considered as consumers of social and other serv-
ices, the societal approach may capture expanded resour-
ces arising from progeny requiring special needs. If this
latter circumstance were the case, it would be balanced by
the fact that these children ultimately will give back to
their families and to society in many ways, thus reducing
ultimate time lost from work when the generations over-
lap.
Intracytoplasmic sperm injection (ICSI) is an assisted
reproduction technique that involves micro-injecting a
single sperm into an oocyte. Including consumables, per-
sonnel, and facility costs, the incremental cost per live
birth (for patients unsuited for conventional IVF) has been
estimated in an Australian study to be between US$8,594
(A$8,500) and US$13,548 (A $13,400) (where: A$1 = US
$1.01104, xe.com), or approximately three times the cost
of standard IVF in Australia [52]. Taking the mean of these
estimates would yield $11,071 per additional ICSI-live
birth. In Australia and elsewhere, ICSI is classified as an
“expanded procedure” associated with additional out-of-
pocket expense for patients. This could limit access to IVF
by rendering the entire procedure unaffordable for some
individuals, with procedural point costs far exceeding
these weighted costs (per live birth). In contrast, if the
procedure is purchased the expenditure would likely
exhaust any discretionary money that might otherwise be
available for emergency health or family needs.
Figure 3: Proposed investigative model for supplementation trials to assess impact of various interventions on male reproductive potential.
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nMore than 2 billion people worldwide may be affected by
mineral and/or vitamin deficiencies [51]. A USAID study
of outreach programs in Ghana, Nepal, and Zambia esti-
mated that the average cost per child dosed twice per year
with Vitamin A would be about forty cents (US$1.15
when costs included personnel and capital items such as
vehicles, office provisions, and long-term training) [53].
Assuming a 20-year cost of multi-vitamin supplementa-
tion at 10 times the higher annual amount cited above (US
$11.50 per year), and a 30yr interval to have offspring with
their partner, $345 would still be far less than one ICSI
intervention or conventional IVF. Under these rather con-
servative assumptions of a 30-year fertile period for the
male, averting the cost of one ICSI procedure could easily
pay for the 30-year multi-vitamin supplementation of 32
individuals. Adopting the society-as-payer or human cap-
ital perspectives would certainly expand this cost-offset
attributable to early and effective intervention. In other
settings, the cost differential between nutritional supple-
mentation vs. IVF+ICSI is even more pronounced.
Whereas a 1-month supply of nutritional supplements
ranges in currency-adjusted costs from US $13.15 to
$186.00, IVF costs range from US $1,096 to $3,289.
Under such circumstances, IVF costs range 6 to 250 times
the cost of supplementation with no additional benefits.
Health economists call this type of cost-minimization
comparison a dominant decision because, when outcomes
are equal, the choice of comparator is the less expensive
option, which in this case is timely supplementation. With
absolute costs of IVF and ICSI amounting to $9,500 and
an additional $1,200, respectively [54], the cost analysis
presented above is likely to underestimate the putative
value of supplementation in comparison to downstream
care for male subfertility.
Assisted fertility options in the
Developing World
The use of assisted conception in the developing world
traditionally has drawn controversy [55]. Nevertheless,
there are social and economic consequences to childless-
ness in the developing world [56]. Whereas in tropical
regions, health-related priorities focus on treating infec-
tious diseases rather than subfertility and family size tend
to be larger than in other parts of the world, subfertility
still represents a substantial, cultural, economic, and med-
ical problem. According to the WHO, involuntary child-
lessness is a problem that affects all populations at more
or less the same incidence of 1 in 6 couples [57]. In the
developing world, access to advanced reproductive tech-
nology is limited and only the wealthy have the ability to
pay for it; this makes vitamin supplementation not just a
cost-effective option, but the only option available for the
majority in poor populations. Prioritizing vitamin supple-
mentation in such settings would meet Millennium Devel-
opment Goals in addition to mitigating male subfertility.
This type of double-benefit is known as a positive exter-
nality, because it extends beyond the initial targeted unit
of beneficence.
Conclusion
The concept of subfertility is evolving, especially as it
relates to males. Whereas in the past men may have been
classified as infertile when they were unable to father a
child, it currently is recognized that many such individuals
indeed are capable of becoming fathers. Among the fac-
tors that may temporarily prevent a given man from
impregnating his partner is some form of micronutrient/
mineral insufficiency. Several micronutrients have been
shown to improve reproductive outcome when adminis-
tered to subfertile men, but it is not clear whether such
deficiencies act alone or in synergy with other factors. To
date, questions on best therapeutic practice regarding vita-
min supplementation have been addressed insufficiently.
Considering the extent of subfertility on a worldwide basis
and the stress it places on couples desiring a child, it seems
prudent to at least consider multivitamin supplementation
as an early and essential broad-based therapeutic inter-
vention for both males and females. Such a benign inter-
Table 1.
Basic cost analysis models to estimate multi-generational expenditure related to alternative approaches to treating
involuntary childlessness
Perspective
  Costing Inputs
  Definition
 
Projected cost (generation
n)
 
Projected cost (generation
n+1)
 
Ingredients Consumables, personnel
time, cost or price of proce-
dures
Inputs identified and
assigned unit costs
$ $
Society-as-Payer Expanded resources such as
cost of specialty care and
social services
Inputs include wider social
and educational expenditures
$$ $$$
Human Capital
  Wages lost because of days
missed from work, school,
caregiving
 
Inputs focused on individual
as wage-earner and contribu-
tor to society
 
$$$
  $$
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nvention is less expensive and more accessible in many
areas of the world where specialist medical care for infer-
tility is out of reach for the vast majority of the population.
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